We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$1.82B
AUM Growth
-$379K
Cap. Flow
-$119M
Cap. Flow %
-6.53%
Top 10 Hldgs %
44.11%
Holding
149
New
46
Increased
18
Reduced
22
Closed
49

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.77%
2 Healthcare 12.31%
3 Consumer Staples 12.26%
4 Communication Services 9.07%
5 Energy 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNXP icon
76
Tonix Pharmaceuticals
TNXP
$233M
0
ENTL
77
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$4.12M 0.23%
225,280
FATE icon
78
Fate Therapeutics
FATE
$291M
$3.84M 0.21%
2,257,920
GWPH
79
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.75M 0.21%
+41,000
New +$3.45M
GEG icon
80
Great Elm Group
GEG
$67.7M
$3.59M 0.2%
545,020
ARAV
81
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.5M 0.19%
52,707
+15,833
+43% +$900K
VNDA icon
82
CALL
Vanda Pharmaceuticals
VNDA
$320M
$3.36M 0.18%
+300,000
New +$2.91M
MDVN
83
DELISTED
MEDIVATION, INC.
MDVN
$2.84M 0.16%
+47,100
New +$2.67M
XLP icon
84
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$2.76M 0.15%
+50,000
New +$2.66M
ALPN
85
DELISTED
Alpine Immune Sciences Inc
ALPN
$2.49M 0.14%
135,425
+71,287
+111% +$1.27M
TSRO
86
CALL
DELISTED
TESARO, Inc.
TSRO
$2.1M 0.12%
+25,000
New +$1.11M
IVTY
87
DELISTED
Invuity, Inc
IVTY
$2.09M 0.11%
219,150
-25,000
-10% -$174K
HCA icon
88
HCA Healthcare
HCA
$90.5B
$1.98M 0.11%
25,752
-20,000
-44% -$1.58M
JAGX icon
89
Jaguar Health
JAGX
$4.19M
0
CBAY
90
DELISTED
Cymabay Therapeutics
CBAY
$1.67M 0.09%
958,822
-98
-0% -$203
AZN icon
91
CALL
AstraZeneca
AZN
$252B
$1.55M 0.09%
+25,650
New +$1.49M
ATRS
92
DELISTED
Antares Pharma, Inc.
ATRS
$1.34M 0.07%
1,278,868
-34,380
-3% -$33.2K
C icon
93
Citigroup
C
$223B
$1.26M 0.07%
+29,740
New +$1.32M
ZVRA icon
94
Zevra Therapeutics
ZVRA
$687M
$1.03M 0.06%
16,248
+1,359
+9% +$224K
MDWD icon
95
MediWound
MDWD
$163M
$667K 0.04%
12,084
AAL icon
96
American Airlines Group
AAL
$9.03B
$338K 0.02%
450,000
AMAT icon
97
Applied Materials
AMAT
$366B
-200,000
Closed -$4.24M
ARMK icon
98
Aramark
ARMK
$15.3B
-200,825
Closed -$4.8M
BHC icon
99
CALL
Bausch Health
BHC
$2.36B
-150,000
Closed -$3.94M
CVS icon
100
CVS Health
CVS
$119B
-91,000
Closed -$9.44M

Similar funds

Kingdon Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Kingdon Capital Management held 149 positions worth $1.82B, down 0.02% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management withdrew a net $119M in Q2 2016, closing 49 positions and reducing 22 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Kingdon Capital Management opened a new position in EMC CORPORATION worth $39.7M.

  • Kingdon Capital Management's largest Q2 2016 buy was EMC CORPORATION: 1,462,300 shares worth $39.7M.
  • Kingdon Capital Management added most to Newell Brands in Q2 2016, an estimated $88.1M increase.
  • Kingdon Capital Management's biggest Q2 2016 reduction was Alphabet (Google) Class A, cutting an estimated $65.4M.
  • Kingdon Capital Management fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $98.4M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.82B portfolio in Q2 2016.
  • Kingdon Capital Management opened 46 new positions and closed 49 in Q2 2016.
  • Kingdon Capital Management's portfolio value fell 0.02% quarter-over-quarter to $1.82B.

Based on Kingdon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.